Source:http://linkedlifedata.com/resource/pubmed/id/12054346
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-6-10
|
pubmed:abstractText |
The PEA3 group members PEA3, ER81 and ERM, which are highly conserved transcription factors from the Ets family, are over-expressed in metastatic mammary tumors. In the current study, we present the characterization of a transgenic mouse strain which over-expresses ER81 in the mammary gland via the long terminal repeat of the mouse mammary tumor virus (LTR-MMTV). Although six genotypically positive transgenic lines were identified, only one expressed the ectopic transcript with an exclusive expression in the lactating and late-pregnancy (18th day) mammary glands. No mammary tumor or mammary deregulation appeared after 2 years of ectopic ER81 expression following lactation. We then sought to identify ER81 target genes, and the urokinase plasminogen activator (uPA) and the stromelysin-1, two enzymes involved in extracellular matrix degradation, were found to be transcriptionally upregulated in lactating mammary glands over-expressing ER81. Since these enzymes are involved in metastasis, this murine model could be further used to enhance mammary cancer metastatic process by crossing these animals with mice carrying non-metastatic mammary tumors. We thus created a transgenic mouse model permitting the over-expression of a functionally active Ets transcription factor in the mammary gland without perturbing its development.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Etv1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0962-8819
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
123-31
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12054346-Animals,
pubmed-meshheading:12054346-DNA-Binding Proteins,
pubmed-meshheading:12054346-Female,
pubmed-meshheading:12054346-Gene Expression Regulation,
pubmed-meshheading:12054346-Genetic Vectors,
pubmed-meshheading:12054346-Male,
pubmed-meshheading:12054346-Mammary Glands, Animal,
pubmed-meshheading:12054346-Mammary Tumor Virus, Mouse,
pubmed-meshheading:12054346-Matrix Metalloproteinase 3,
pubmed-meshheading:12054346-Mice,
pubmed-meshheading:12054346-Mice, Inbred C57BL,
pubmed-meshheading:12054346-Mice, Transgenic,
pubmed-meshheading:12054346-Promoter Regions, Genetic,
pubmed-meshheading:12054346-Transcription Factors,
pubmed-meshheading:12054346-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2002
|
pubmed:articleTitle |
Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.
|
pubmed:affiliation |
UMR 8526 CNRS, Institut de Biologie de Lille, Institut Pasteur de Lille, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|